Gameto Secures $33M To Support Clinical Development of Fertility Treatment – MedCity News
Gameto, a biotechnology company, has raised $33 million in Series B funding, which it will use to support the clinical development of its in vitro maturation (IVM) product called Fertilo.
New York City-based Gameto develops…
Continue Reading